Evidence map›Paper›PMID 28511680›Full record

ArticleSubstance abuse treatment, prevention, and policy2017

Cohort profile: seek, test, treat and retain United States criminal justice cohort.

Redonna Chandler, Michael S Gordon, Bridget Kruszka, Lauren N Strand, Frederick L Altice, Curt G Beckwith, Mary L Biggs, William Cunningham, J A Chris Delaney, Patrick M Flynn and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Abnormal Pap Follow-Up among Criminal-Legal Involved Women in Three U.S. Cities.International journal of environmental research and public health · 2021
    Article
  12. Article
  13. Impact of Abstinence and of Reducing Illicit Drug Use Without Abstinence on Human Immunodeficiency Virus Viral Load.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Redonna ChandlerDivision of Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Washington, DC, USA.
Michael S GordonFriends Research Institute, Baltimore, MD, USA.
Bridget KruszkaDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Lauren N StrandDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Frederick L AlticeMedicine and Epidemiology, Yale School of Medicine, New Haven, CT, USA.
Curt G BeckwithDivision of Infectious Diseases, Alpert Medical School of Brown University, Providence, RI, USA.
Mary L BiggsDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
William CunninghamDepartment of Health Policy and Management, Medicine, General Internal Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
J A Chris DelaneyDepartment of Epidemiology, University of Washington, Seattle, WA, USA.
Patrick M FlynnTexas Christian University, Fort Worth, TX, USA.
Carol E GolinDepartments of Health Behavior and Medicine, University of North Carolina, Chapel Hill, NC, USA.
Kevin KnightInstitute of Behavior Research, Texas Christian University, Fort Worth, TX, USA.
Alex H KralUrban Health Program, RTI International, Research Triangle Park, NC, USA.
Irene KuoDepartment of Epidemiology and Biostatistics, The George Washington University, Washington, DC, USA.
Jennifer LorvickUrban Health Program, RTI International, Research Triangle Park, NC, USA.
Robin M NanceDepartment of Medicine, University of Washington, Seattle, WA, USA.
Lawrence J OuelletDepartment of Epidemiology, University of Illinois at Chicago, Chicago, IL, USA.
Josiah D RichMedicine and Epidemiology, Brown University, Center for Prisoner Health and Human Rights, The Miriam Hospital, Providence, RI, USA.
Stanley SacksCenter for the Integration of Research & Practice (CIRP), National Development & Research Institutes, Inc. (NDRI), New York, NY, USA.
David SealDepartment of Global Community Health and Behavioral Sciences, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Anne SpauldingDepartment of Epidemiology, Emory University, Atlanta, GA, USA.
Sandra A SpringerDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Faye TaxmanDepartment of Criminology, Law and Society, George Mason University, Fairfax, VA, USA.
David WohlSchool of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Jeremy D YoungInfectious Disease Fellowship Program, University of Illinois at Chicago, Chicago, USA.
Rebekah YoungDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Heidi M CraneSchool of Medicine, University of Washington, Seattle, WA, USA. hcrane@uw.edu.

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Nina Thawata Harawa · 1997 to 2026
$53.5M
Justice Community Opioid Innovation Network (JCOIN): TCU Clinical Research CenterUG1DA050074 · NIDA · TEXAS CHRISTIAN UNIVERSITY · PI KNIGHT, DANICA K, KNIGHT, KEVIN · 2019 to 2023
$10.1M
Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIVR01DA032083 · NIDA · NEW YORK UNIVERSITY · PI GWADZ, MARYA · 2011 to 2015
$7.5M
RCT of an augmented test, treat, link, & retain model for NC and Texas prisonersR01DA030793 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLYNN, PATRICK M, GOLIN, CAROL E · 2010 to 2015
$6.9M
HIV Testing and Treatment to Prevent Onward HIV Transmission among High-risk MSMR01DA032106 · NIDA · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DUERR, ANN C · 2011 to 2015
$6.6M
Integrated Care Clinics for IDUs in India: a cluster randomized trialR01DA032059 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LUCAS, GREGORY M, MEHTA, SHRUTI H · 2011 to 2015
$6.3M
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine UsersR01DA032098 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DEL RIO, CARLOS, METSCH, LISA R · 2011 to 2015
$6.2M
CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)R01DA030747 · NIDA · MIRIAM HOSPITAL · PI BECKWITH, CURT G, KUO, IRENE · 2010 to 2014
$4.9M
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV CareR01DA030781 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CUNNINGHAM, WILLIAM EMERY · 2010 to 2015
$4.5M
NCATS NIH HHS UL1 TR001863NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI050410NIDA NIH HHS R01 DA030747NIDA NIH HHS R01 DA030762NIDA NIH HHS R01 DA030766NIDA NIH HHS R01 DA030768NIDA NIH HHS R01 DA030770NIDA NIH HHS R01 DA030771NIDA NIH HHS R01 DA030776NIDA NIH HHS R01 DA030778NIDA NIH HHS R01 DA030781NIDA NIH HHS R01 DA030793NIDA NIH HHS R01 DA032057NIDA NIH HHS R01 DA032059NIDA NIH HHS R01 DA032061NIDA NIH HHS R01 DA032080NIDA NIH HHS R01 DA032082NIDA NIH HHS R01 DA032083NIDA NIH HHS R01 DA032098NIDA NIH HHS R01 DA032100NIDA NIH HHS R01 DA032106NIDA NIH HHS R01 DA032110NIDA NIH HHS R34 DA035728NIDA NIH HHS U01 DA037702NIMH NIH HHS P30 MH058107NIMH NIH HHS R01 MH094090
6 · The paper itself

Abstract

backgroundThe STTR treatment cascade provides a framework for research aimed at improving the delivery of services, care and outcomes of PLWH. The development of effective approaches to increase HIV diagnoses and engage PLWH in subsequent steps of the treatment cascade could lead to earlier and sustained ART treatment resulting in viral suppression. There is an unmet need for research applying the treatment cascade to improve outcomes for those with criminal justice involvement.

methodsThe Seek, Test, Treat, and Retain (STTR) criminal justice (CJ) cohort combines data from 11 studies across the HIV treatment cascade that focused on persons involved in the criminal justice system, often but not exclusively for reasons related to substance use. The studies were conducted in a variety of CJ settings and collected information across 11 pre-selected domains: demographic characteristics, CJ involvement, HIV risk behaviors, HIV and/or Hepatitis C infections, laboratory measures of CD4 T-cell count (CD4) and HIV RNA viral load (VL), mental illness, health related quality of life (QoL), socioeconomic status, health care access, substance use, and social support.

resultsThe STTR CJ cohort includes data on 11,070 individuals with and without HIV infection who range in age from 18 to 77 years, with a median age at baseline of 37 years. The cohort reflects racial, ethnic and gender distributions in the U.S. CJ system, and 64% of participants are African-American, 12% are Hispanic and 83% are men. Cohort members reported a wide range of HIV risk behaviors including history of injection drug use and, among those who reported on pre-incarceration sexual behaviors, the prevalence of unprotected sexual intercourse ranged across studies from 4% to 79%. Across all studies, 53% percent of the STTR CJ cohort reported recent polysubstance use.

conclusionsThe STTR CJ cohort is comprised of participants from a wide range of CJ settings including jail, prison, and community supervision who report considerable diversity in their characteristics and behavioral practices. We have developed harmonized measures, where feasible, to improve the integration of these studies together to answer questions that cannot otherwise be addressed.

Indexed as

Criminal LawAdolescentAdultAgedCohort StudiesComorbidityFemaleHealth Services AccessibilityHepatitis CHIV InfectionsHumansMaleMental DisordersMiddle AgedQuality of LifeRisk FactorsCriminal justiceData harmonization.HIV

Identifiers

PMID28511680
PMCPMC5433052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.